Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TRILITRON

PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE

Standard Dose
30MG/5ML;1.25MG/5ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview TRILITRON is listed in Drugs@FDA under application 088474 (ANDA).

Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 30MG/5ML;1.25MG/5ML Sponsor NEWTRON PHARMS Submission history Latest submission status date: 1985-02-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview TRILITRON is listed in Drugs@FDA under application 088474 (ANDA). Marketing status: Discontinued Active ingredient PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE Form and strength SYRUP;ORAL - 30MG/5ML;1.25MG/5ML Sponsor NEWTRON PHARMS Submission history Latest submission status date: 1985-02-12 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
TRILITRON (PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE) | Drug Monograph | MedicHelpline